155 related articles for article (PubMed ID: 21947269)
1. Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome.
Di Vinci A; Casciano I; Marasco E; Banelli B; Ravetti GL; Borzì L; Brigati C; Forlani A; Dorcaratto A; Allemanni G; Zona G; Spaziante R; Gohlke H; Gardin G; Merlo DF; Mantovani V; Romani M
J Cancer Res Clin Oncol; 2012 Jan; 138(1):35-47. PubMed ID: 21947269
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
[TBL] [Abstract][Full Text] [Related]
3. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis.
Gonçalves CS; Xavier-Magalhães A; Martins EP; Pinto AA; Pires MM; Pinheiro C; Reis RM; Sousa N; Costa BM
Mol Oncol; 2020 Jun; 14(6):1224-1241. PubMed ID: 31923345
[TBL] [Abstract][Full Text] [Related]
4. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
5. Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma.
Costa BM; Smith JS; Chen Y; Chen J; Phillips HS; Aldape KD; Zardo G; Nigro J; James CD; Fridlyand J; Reis RM; Costello JF
Cancer Res; 2010 Jan; 70(2):453-62. PubMed ID: 20068170
[TBL] [Abstract][Full Text] [Related]
6. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.
Zheng S; Houseman EA; Morrison Z; Wrensch MR; Patoka JS; Ramos C; Haas-Kogan DA; McBride S; Marsit CJ; Christensen BC; Nelson HH; Stokoe D; Wiemels JL; Chang SM; Prados MD; Tihan T; Vandenberg SR; Kelsey KT; Berger MS; Wiencke JK
Neuro Oncol; 2011 Mar; 13(3):280-9. PubMed ID: 21339190
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.
Wu X; Wu F; Xu D; Zhang T
J Neurooncol; 2016 Apr; 127(2):221-32. PubMed ID: 26757925
[TBL] [Abstract][Full Text] [Related]
8. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer.
Song YP; Xian P; Luo H; Dai JY; Bai Y; Li Y; Tang XL
J Immunol Res; 2022; 2022():5740971. PubMed ID: 35372588
[TBL] [Abstract][Full Text] [Related]
10. HOTAIRM1, an enhancer lncRNA, promotes glioma proliferation by regulating long-range chromatin interactions within HOXA cluster genes.
Shi T; Guo D; Xu H; Su G; Chen J; Zhao Z; Shi J; Wedemeyer M; Attenello F; Zhang L; Lu W
Mol Biol Rep; 2020 Apr; 47(4):2723-2733. PubMed ID: 32180085
[TBL] [Abstract][Full Text] [Related]
11. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
12. Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population.
Palani M; Devan S; Arunkumar R; Vanisree AJ
Med Oncol; 2011 Dec; 28 Suppl 1():S445-52. PubMed ID: 20844987
[TBL] [Abstract][Full Text] [Related]
13. DNA Methylation Analysis Identifies Patterns in Progressive Glioma Grades to Predict Patient Survival.
Weng JY; Salazar N
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498463
[TBL] [Abstract][Full Text] [Related]
14. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.
Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG
Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718
[TBL] [Abstract][Full Text] [Related]
15. HOXA10‑AS: A novel oncogenic long non‑coding RNA in glioma.
Dong CY; Cui J; Li DH; Li Q; Hong XY
Oncol Rep; 2018 Nov; 40(5):2573-2583. PubMed ID: 30132568
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
[TBL] [Abstract][Full Text] [Related]
17. Correlation between deregulated expression of PER2 gene and degree of glioma malignancy.
Wang F; Luo Y; Li C; Chen L
Tumori; 2014; 100(6):e266-72. PubMed ID: 25688509
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.
Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X
Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation-mediated caspase-8 downregulation is associated with anti-apoptotic activity and human malignant glioma grade.
Teng Y; Dong YC; Liu Z; Zou Y; Xie H; Zhao Y; Su J; Cao F; Jin H; Ren H
Int J Mol Med; 2017 Mar; 39(3):725-733. PubMed ID: 28204824
[TBL] [Abstract][Full Text] [Related]
20. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]